← back to search

Matt A. Bernstein

University of London ·
Area of research
Radiology, Nuclear Medicine and Imaging · Psychiatry and Mental health
Research interest
Research interests include Advanced MRI Techniques and Applications, Advanced Neuroimaging Techniques and Applications, Dementia and Cognitive Impairment Research, and Functional Brain Connectivity Studies.
h-index
83
citations
26,071
works
476
NIH funding
primary concept
email

Recent publications

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Scientific Reports 2024cited by 26position: middledoi
A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer’s disease
Alzheimer s Research & Therapy 2024cited by 17position: middledoi
Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
Communications Medicine 2023cited by 69position: middledoi
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
JAMA Neurology 2023cited by 43position: middledoi
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression
JAMA Psychiatry 2022cited by 145position: middledoi
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Nature Communications 2022cited by 129position: middledoi
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease
Nature Aging 2022cited by 46position: middledoi
Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
Nature Communications 2022cited by 43position: middledoi
The trend of disruption in the functional brain network topology of Alzheimer’s disease
Scientific Reports 2022cited by 40position: middledoi
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
JAMA Neurology 2021cited by 319position: middledoi
Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
Nature Communications 2021cited by 100position: middledoi
A deep learning framework identifies dimensional representations of Alzheimer’s Disease from brain structure
Nature Communications 2021cited by 99position: middledoi
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
Nature Communications 2021cited by 67position: middledoi
Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
Scientific Reports 2021cited by 31position: middledoi
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Nature Communications 2020cited by 534position: middledoi
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
Nature Communications 2020cited by 339position: middledoi
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology
Scientific Reports 2020cited by 134position: middledoi
Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau
Brain Communications 2020cited by 85position: middledoi
FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease
Nature Communications 2020cited by 32position: middledoi
A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease
Scientific Reports 2020cited by 20position: middledoi
Predicting Alzheimer’s disease progression using multi-modal deep learning approach
Scientific Reports 2019cited by 398position: middledoi
Non-coding variability at the APOE locus contributes to the Alzheimer’s risk
Nature Communications 2019cited by 123position: middledoi
Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3
Frontiers in Neuroinformatics 2019cited by 119position: middledoi
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
Nature Communications 2019cited by 114position: middledoi
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics
Scientific Reports 2019cited by 93position: middledoi
Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification
Scientific Reports 2019cited by 47position: middledoi
A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data
Scientific Reports 2019cited by 26position: middledoi
Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis
Proceedings of the National Academy of Sciences 2018cited by 103position: middledoi
Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease
Scientific Reports 2018cited by 27position: middledoi
Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns
Scientific Reports 2017cited by 83position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael W. Weiner · Hôpital Beau-Séjour6 papers (2012–2019)Clifford R. Jack · ADS Group6 papers (2012–2019)Paul M. Thompson · Lieber Institute for Brain Development5 papers (2012–2019)Neda Jahanshad · ADS Group3 papers (2014–2019)Talia M. Nir · University of Southern California3 papers (2014–2019)Jeffrey L. Gunter · Mayo Clinic2 papers (2012–2012)Matthew L. Senjem · Mayo Clinic2 papers (2012–2012)Félix W. Wehrli · University of California System1 papers (2014–2014)Xue Hua · Shenzhen University1 papers (2015–2015)Leslie M. Shaw · Siemens (United States)1 papers (2012–2012)David Hill · The University of Melbourne1 papers (2012–2012)Han Wen · National Heart Lung and Blood Institute1 papers (2015–2015)Bob S. Hu · Palo Alto University1 papers (2015–2015)Derrek P. Hibar · Genesys (United States)1 papers (2015–2015) · 1 papers (2012–2012) · 1 papers (2015–2015) · 1 papers (2014–2014)Heather J. Wiste · Mayo Clinic in Florida1 papers (2012–2012)for the Alzheimer’s Disease Neuroimaging Initiative · San Francisco VA Medical Center1 papers (2012–2012)Shantanu H. Joshi · University of California, Los Angeles1 papers (2014–2014)